The interactions between cells and the extracellular matrix (ECM) play a major role in normal and pathological conditions. The ECM can modulate several biological functions including cell proliferation, adhesion, differentiation and survival through its interactions with cell receptors. Laminins are one of the most important glycoproteins present in basement membranes, a type of ECM. The pattern of expression of its different isoforms depends on the spatiotemporal organization of each tissue. While integrins are the most studied laminin receptors, other non-integrin laminin receptors are also involved. This review focuses on two particular nonintegrin laminin receptors in the epithelial context: dystroglycan and 37/67 laminin receptor (37/67LR). Dystroglycan is a two-subunit protein discovered in the muscle as part of the dystrophin-associated glycoprotein complex. This protein can also be found in many epithelia where its roles are variable. The 37/67LR is a still incompletely understood laminin receptor that is important to regulate intestinal epithelial cell function and could be involved in various pathological conditions.
Primary cilia are sensory antennae located at the cell surface which mediate a variety of extracellular signals involved in development, tissue homeostasis, stem cells and cancer. Primary cilia are found in an extensive array of vertebrae cells but can only be generated when cells become quiescent. The small intestinal epithelium is a rapidly self-renewing tissue organized into a functional unit called the crypt–villus axis, containing progenitor and differentiated cells, respectively. Terminally differentiated villus cells are notoriously devoid of primary cilia. We sought to determine if intestinal crypts contain a quiescent cell population that could be identified by the presence of primary cilia. Here we show that primary cilia are detected in a subset of cells located deep in the crypts slightly above a Paneth cell population. Using a normal epithelial proliferative crypt cell model, we show that primary cilia assembly and activity correlate with a quiescent state. These results provide further evidence for the existence of a quiescent cell population in the human small intestine and suggest the potential for new modes of regulation in stem cell dynamics.
The 67 kDa laminin receptor (67LR) was identified as the first laminin receptor shown to be involved in the carcinogenesis of various cancers, including colorectal cancer. While the exact composition of this 67 kDa receptor remains unknown, it has been reported to be formed by the 37 kDa ribosomal protein SA (RPSA) covalently attached to another unidentified protein. The goal of this study was to clarify the molecular structure of 67LR to enhance our understanding of its role in malignancies. Using cell fractionation of colorectal cancer cells, the 67 kDa immunoreactive protein corresponding to 67LR was found in the soluble protein fraction, while some of the 37 kDa RPSA exhibited plasma membrane-like properties. Proteomic analysis of the 67 kDa fraction revealed the absence of RPSA but identified the β-galactosidase-related 67 kDa elastin-binding protein (67EBP), another laminin binding receptor which presents amino acid sequence similarities that can explain the immune cross reactivity with RPSA. The downregulation of β-galactosidase through short hairpin RNA (shRNA) led to a reduction in both 67LR and 67EBP immunoreactive proteins, confirming the misidentification of 67LR and 67EBP in colorectal cancer cells. Based on these findings, we propose to redefine the 67LR as the RPSA-containing laminin receptor (RCLR) to avoid confusion with the 67EBP.
The role of laminin receptors in colorectal cancer (CRC) is the subject of ongoing research. Histopathological studies have suggested that the 67 kDa laminin receptor (67LR) is involved in the carcinogenesis of various malignancies, including CRC. However, the exact composition and nature of 67LR have been a source of confusion for many years. A recent study from our group reported that the 37 kDa form of RPSA participates as a laminin receptor renamed the RPSA-containing laminin receptor (RCLR) but is not the precursor form of the 67LR since the 67 kDa protein associated with 67LR corresponds to the 67 kDa elastin-binding protein (67EBP), which also acts as a laminin receptor. The present study aims to analyze the distinct expression patterns of these two laminin receptor components in CRC. Expressions of RCLR and 67EBP were analyzed in CRC tissues using Western blot and quantitative RT-PCR analyses. The primary colorectal adenocarcinoma tissues and corresponding resection margins showed an overexpression of both RPSA and 67EBP at the protein level in the CRC tissues. An analysis of the publicly available CRC datasets confirmed the overexpression of RPSA and 67EBP in CRC tissues. In conclusion, the elevated expression of these two non-integrin laminin receptors in CRC lesions suggests their critical roles in colorectal carcinogenesis and emphasizes their potential usefulness as tissue biomarkers.
21 February 2022 in Journal of the Canadian Association of Gastroenterology
The interaction between cells and extracellular matrix components like laminin or elastin is a crucial step in cancer development and the metastasis process. The 67 kDa Laminin Receptor (67LR) was one of the first cell surface receptors for laminin to be discovered in the 1980s. The 67LR has been reported to be the cytoplasmic 37 kDa small ribosomal subunit protein RPSA (40S ribosomal protein SA) combined with another yet to be identified component to become the 67 kDa membrane receptor. The mechanism by which the ribosomal protein becomes the 67LR membrane receptor is still unclear, but it is presumed that the process involves post-translational modifications combined with homo or hetero-dimerization with non-associated ribosomal proteins. Interestingly, the 67LR confers aggressiveness and a poor prognosis to a wide variety of cancers. The aim of this study was to confirm the overexpression of 67LR at the membrane of colorectal cancer cells (CRC) and to identify its homo or hetero-dimerization partners. To detect the expression of 67LR in colorectal cancer we performed indirect immunofluorescence on tissues from normal and diseased colons. To confirm the presence of 67LR at the membrane of CRC cells we used a cellular fractionation protocol combined with ultracentrifugation and detergent treatment to separate ribosome-containing fractions from the membranes to isolate membrane associated 67LR-related components. Mass spectrometry analysis to study the molecular identity of 67LR was performed on immunoreactive bands corresponding to RPSA and 67LR from different subcellular fractions. Immunolocalization of 67LR revealed an overexpression in colorectal cancer tissues. Following analysis by western blotting a 67 kDa immunoreactive protein was found in the supernatant of the 210,000 x g centrifugation while a 37 kDa protein was detected in the pellet solubilized with detergent, suggesting that the 37 kDa form is associated with the membrane. Furthermore, mass spectrometry analysis of the 67 kDa immunoreactive band present in the soluble fraction did not identify any RPSA-related peptides but found a 67 kDa elastin binding receptor (67EBP) related peptide, an elastin receptor that can also bind laminin. The identity of the 67EBP was then confirmed using a shRNA knockdown approach. These results suggest a possible confusion between the 67 kDa laminin receptor (67LR) and 67 kDa elastin receptor (67EBP) and the possibility that the 37 kDa protein acts as a cell membrane laminin receptor. CIHR